Return to homepagePandemic Pact

Task V7: Clinical and NHP Sample Testing for SARS-CoV-2 Biological Product Candidates

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201800013I-P00002-759302000004-3

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2022

  • Known Financial Commitments (USD)

    $172,276

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    Thomas Rudge

  • Research Location

    United States of America

  • Lead Research Institution

    Battelle Centers/Pub Hlth Res & Evaluatn

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new biologics (regulated by CBER) against potential agents of bioterrorism and emerging and re-emerging infectious diseases.